EXENS Stock Overview
Engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Exosens Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €18.90 |
| 52 Week High | €24.95 |
| 52 Week Low | €16.84 |
| Beta | 0 |
| 1 Month Change | -7.87% |
| 3 Month Change | -3.85% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -16.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| EXENS | FR Aerospace & Defense | FR Market | |
|---|---|---|---|
| 7D | 6.2% | -0.4% | -1.8% |
| 1Y | n/a | 17.2% | -4.9% |
Return vs Industry: Insufficient data to determine how EXENS performed against the French Aerospace & Defense industry.
Return vs Market: Insufficient data to determine how EXENS performed against the French Market.
Price Volatility
| EXENS volatility | |
|---|---|
| EXENS Average Weekly Movement | 5.9% |
| Aerospace & Defense Industry Average Movement | 3.6% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.5% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: EXENS has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: EXENS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 1,600 | Jerome Cerisier | www.exosens.com |
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultra violet, short and long wave infrared, visible - near infrared, and mid wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for scientific applications; and gamma and neutron detectors, and mineral insulated extensions. The company also provides power tubes and microwave devices; and methane airborne detection solutions.
Exosens Fundamentals Summary
| EXENS fundamental statistics | |
|---|---|
| Market cap | €959.79m |
| Earnings (TTM) | €1.95m |
| Revenue (TTM) | €353.72m |
491.2x
P/E Ratio2.7x
P/S RatioIs EXENS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EXENS income statement (TTM) | |
|---|---|
| Revenue | €353.72m |
| Cost of Revenue | €151.72m |
| Gross Profit | €202.00m |
| Other Expenses | €200.05m |
| Earnings | €1.95m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 03, 2025
| Earnings per share (EPS) | 0.038 |
| Gross Margin | 57.11% |
| Net Profit Margin | 0.55% |
| Debt/Equity Ratio | 65.6% |
How did EXENS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 22:24 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Exosens is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Laurent Gelebart | BNP Paribas Exane |
| Charles Armitage | Citigroup Inc |
| David Perry | J.P. Morgan |